MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

O M Fisher; A J Levert-Mignon; S J Lord; K K M Lee-Ng; N K Botelho; Dan Falkenback; M L Thomas; Y V Bobryshev; D C Whiteman; D A Brown; S N Breit; R V Lord

doi:10.1038/bjc.2015.100

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

O M Fisher, A J Levert-Mignon, S J Lord, K K M Lee-Ng, N K Botelho, Dan Falkenback, M L Thomas, Y V Bobryshev, D C Whiteman, D A Brown, S N Breit, R V Lord

Surgery (Lund)

Research output: Contribution to journal › Article › peer-review

230 Downloads (Pure)

Abstract

Biomarkers are needed to improve current diagnosis and surveillance strategies for patients with Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC). Macrophage inhibitory cytokine 1/growth differentiation factor 15 (MIC-1/GDF15) tissue and plasma levels have been shown to predict disease progression in other cancer types and was therefore evaluated in BO/OAC.

Original language	English
Pages (from-to)	1384-1391
Journal	British Journal of Cancer
Volume	112
Issue number	8
DOIs	https://doi.org/10.1038/bjc.2015.100
Publication status	Published - 2015

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bjc.2015.100

NPG_Fisher_et_al

http://www.ncbi.nlm.nih.gov/pubmed/25867265?dopt=Abstract

Cite this

@article{3c56698fbd2d4e95bf7dc8854c04cd96,

title = "MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.",

abstract = "Biomarkers are needed to improve current diagnosis and surveillance strategies for patients with Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC). Macrophage inhibitory cytokine 1/growth differentiation factor 15 (MIC-1/GDF15) tissue and plasma levels have been shown to predict disease progression in other cancer types and was therefore evaluated in BO/OAC.",

author = "Fisher, {O M} and Levert-Mignon, {A J} and Lord, {S J} and Lee-Ng, {K K M} and Botelho, {N K} and Dan Falkenback and Thomas, {M L} and Bobryshev, {Y V} and Whiteman, {D C} and Brown, {D A} and Breit, {S N} and Lord, {R V}",

year = "2015",

doi = "10.1038/bjc.2015.100",

language = "English",

volume = "112",

pages = "1384--1391",

journal = "British Journal of Cancer",

issn = "1532-1827",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

AU - Fisher, O M

AU - Levert-Mignon, A J

AU - Lord, S J

AU - Lee-Ng, K K M

AU - Botelho, N K

AU - Falkenback, Dan

AU - Thomas, M L

AU - Bobryshev, Y V

AU - Whiteman, D C

AU - Brown, D A

AU - Breit, S N

AU - Lord, R V

PY - 2015

Y1 - 2015

N2 - Biomarkers are needed to improve current diagnosis and surveillance strategies for patients with Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC). Macrophage inhibitory cytokine 1/growth differentiation factor 15 (MIC-1/GDF15) tissue and plasma levels have been shown to predict disease progression in other cancer types and was therefore evaluated in BO/OAC.

AB - Biomarkers are needed to improve current diagnosis and surveillance strategies for patients with Barrett's oesophagus (BO) and oesophageal adenocarcinoma (OAC). Macrophage inhibitory cytokine 1/growth differentiation factor 15 (MIC-1/GDF15) tissue and plasma levels have been shown to predict disease progression in other cancer types and was therefore evaluated in BO/OAC.

U2 - 10.1038/bjc.2015.100

DO - 10.1038/bjc.2015.100

M3 - Article

C2 - 25867265

SN - 1532-1827

VL - 112

SP - 1384

EP - 1391

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 8

ER -

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this